Selank 10mg Canada

Technical Specifications

Compound Name: Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro)
Quantity: 10mg per vial
Format: Lyophilized peptide powder
Peptide Length: 7 amino acids
Molecular Weight: Approximately 751.9 g/mol
Purity Standard: ≥98% (HPLC, batch dependent)
Research Classification: Investigational peptide – laboratory research use only

Selank 10mg Canada is supplied as a lyophilized synthetic heptapeptide intended exclusively for laboratory and analytical applications. Each vial contains 10 milligrams of the peptide prepared under controlled handling and quality verification standards appropriate for research material distribution.

This product is classified as an investigational research compound and is not authorized for therapeutic, diagnostic, or consumer use in Canada when supplied in research format.

Research Overview

Selank is a synthetic peptide derived from the endogenous immunomodulatory peptide tuftsin, with structural modifications designed to enhance stability in experimental systems. It has been studied in neuroscience and immunology research contexts for its potential interaction with central nervous system signalling pathways and immune regulatory mechanisms.

Research involving Selank 10mg Canada typically focuses on neurotransmitter modulation, neurotrophic factor expression, and cytokine signalling in laboratory environments. Scientific literature describes Selank as a peptide investigated in experimental models examining stress-response pathways and cognitive signalling processes.

Preclinical studies have evaluated Selank in cell culture and animal models, analyzing GABAergic signalling, monoamine neurotransmitter systems, and gene expression related to neural plasticity. Exploratory clinical investigations have also been conducted in controlled research settings to examine neurophysiological markers.

Selank 10mg Canada is supplied strictly for research purposes. All references to neurological or immunological pathways reflect investigational findings and do not imply authorized clinical or therapeutic application.

Mechanism Overview

Selank is structurally related to tuftsin, a naturally occurring tetrapeptide involved in immune cell activity. The addition of a Pro-Gly-Pro extension enhances resistance to enzymatic degradation in experimental models and supports increased stability in vitro.

In laboratory studies, Selank has been investigated for its influence on gamma-aminobutyric acid (GABA) receptor-related signalling, monoamine neurotransmitter modulation, and brain-derived neurotrophic factor (BDNF) expression. Researchers analyzing Selank 10mg Canada often assess transcriptional changes, receptor interaction dynamics, and electrophysiological responses in neural tissue models.

Selank has also been examined in experimental systems exploring cytokine regulation and immune cell signalling pathways. Mechanistic descriptions remain confined to preclinical and investigational research findings and are presented for educational purposes only.

Clinical Development Context

Selank has been developed and studied in certain international research and clinical programmes, particularly within Eastern European scientific institutions. Some formulations have been authorized in specific jurisdictions under medical supervision.

However, Selank 10mg Canada, supplied in research-grade format, is categorized strictly as an investigational laboratory compound. It is distinct from authorized pharmaceutical preparations and is not approved by Health Canada for prescription use when provided as a research material.

Academic interest in synthetic neuropeptides and immune-modulating peptides remains strong in neuroscience and immunology research institutions.

Regulatory Status in Canada

Selank 10mg Canada is classified as an investigational research peptide. It is not authorized by Health Canada as a therapeutic drug, natural health product, or over-the-counter medication when supplied in research format.

The peptide is provided exclusively for laboratory and analytical purposes and is not intended for human or veterinary administration.

Handling, storage, and study of Selank 10mg in Canada must comply with applicable federal and provincial Canadian regulations governing chemical and biological research materials. Laboratories and research institutions are responsible for maintaining regulatory compliance.

Molecular and Structural Notes

Selank is a heptapeptide composed of the amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. The inclusion of the Pro-Gly-Pro motif enhances structural stability and resistance to proteolytic degradation in experimental systems.

With a molecular weight of approximately 751.9 g/mol, Selank is a relatively small peptide compared to larger neuropeptide hormones. Its compact structure allows researchers to evaluate minimal peptide motifs in controlled laboratory models.

Selank 10mg Canada is typically characterized using analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry to confirm identity and purity before distribution.

The lyophilized format supports peptide stability during storage when maintained under appropriate laboratory conditions.

Frequently Asked Questions

What is Selank 10mg Canada studied for in research?
Selank 10mg Canada is being studied in laboratory settings to investigate neurotransmitter signalling and immune modulation pathways.

Is Selank approved for medical use in Canada?
Health Canada does not authorize research-grade Selank for therapeutic or consumer use.

What type of peptide is Selank?
It is a synthetic tuftsin-derived heptapeptide studied in neuroscience and immunology.

Does Selank 10mg Canada contain additives?
Unless specified in the batch documentation, the vial contains only the lyophilized peptide compound.

Can Selank 10mg Canada be used outside research facilities?
No. It is supplied strictly for controlled laboratory and analytical research purposes.

Educational Disclaimer

Selank 10mg Canada is an investigational research peptide supplied solely for laboratory and analytical use. It is not approved by Health Canada as a medication, therapeutic agent, or consumer product when provided in research-grade form.

The information provided on this page is educational and based on publicly available scientific literature describing investigational research contexts. No medical, diagnostic, or therapeutic claims are made.

Study and handling of Selank 10mg Canada should occur only within properly equipped research facilities and in accordance with applicable Canadian regulations and institutional guidelines.